Your browser doesn't support javascript.
loading
Infradiaphragmatic irradiation and high procarbazine doses increase colorectal cancer risk in Hodgkin lymphoma survivors.
van Eggermond, Anna M; Schaapveld, Michael; Janus, Cécile Pm; de Boer, Jan Paul; Krol, Augustinus Dg; Zijlstra, Josée M; van der Maazen, Richard Wm; Kremer, Leontien C; van Leerdam, Monique E; Louwman, Marieke Wj; Visser, Otto; De Bruin, Marie L; Aleman, Berthe Mp; van Leeuwen, Flora E.
Afiliação
  • van Eggermond AM; Department of Epidemiology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066 CX, The Netherlands.
  • Schaapveld M; Department of Epidemiology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066 CX, The Netherlands.
  • Janus CP; Netherlands Comprehensive Cancer Organisation (IKNL), Hoog Catharijne, Godebaldkwartier 419, Utrecht 3511 DT, The Netherlands.
  • de Boer JP; Department of Radiation Oncology, Erasmus MC Cancer Institute, 's-Gravendijkwal 230, Rotterdam 3015 CE, The Netherlands.
  • Krol AD; Department of Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066 CX, The Netherlands.
  • Zijlstra JM; Division of Radiation Oncology, Leiden University Medical Center, Albinusdreef 2, Leiden 2333 ZA, The Netherlands.
  • van der Maazen RW; Department of Hematology, VU University Medical Center, De Boelelaan 1117, Amsterdam 1081 HV, The Netherlands.
  • Kremer LC; Department of Radiation Oncology, Radboud University Medical Centre, Geert Grooteplein Zuid 10, Nijmegen 6525 GA, The Netherlands.
  • van Leerdam ME; Department of Pediatric Oncology, Emma Children's Hospital/Academic Medical Center, Meibergdreef 9, Amsterdam-Zuidoost 1105 AZ, The Netherlands.
  • Louwman MW; Department of Gastroenterology and Hepatology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Visser O; Netherlands Comprehensive Cancer Organisation (IKNL), Hoog Catharijne, Godebaldkwartier 419, Utrecht 3511 DT, The Netherlands.
  • De Bruin ML; Netherlands Comprehensive Cancer Organisation (IKNL), Hoog Catharijne, Godebaldkwartier 419, Utrecht 3511 DT, The Netherlands.
  • Aleman BM; Department of Pharmacy, Faculty of Health and Medical Science (CORS), University of Copenhagen, Universitetsparken 2, Copenhagen 2100, Denmark.
  • van Leeuwen FE; Department of Radiation Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066 CX, The Netherlands.
Br J Cancer ; 117(3): 306-314, 2017 Jul 25.
Article em En | MEDLINE | ID: mdl-28632726

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Procarbazina / Doença de Hodgkin / Neoplasias Colorretais / Segunda Neoplasia Primária / Colo / Neoplasias Induzidas por Radiação / Antineoplásicos Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Br J Cancer Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Holanda País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Procarbazina / Doença de Hodgkin / Neoplasias Colorretais / Segunda Neoplasia Primária / Colo / Neoplasias Induzidas por Radiação / Antineoplásicos Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Br J Cancer Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Holanda País de publicação: Reino Unido